GSK won patent dispute over ondansetron

Published: 2003-11-13 06:58:00

Updated: 2003-11-13 06:58:00

The Seoul District Court ruled on October 30 that Asia Pharm's Zapron had violated the local patent of GlaxoSmithKline's ondansetron (brandname: Zofran) in a patent dispute filed by GSK Korea on March 2002, following its successful second patent litigation against Hana Pharm's ondansetron on Apri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK